首页 | 官方网站   微博 | 高级检索  
     

清开灵注射液辅助治疗小儿肺炎有效性和安全性的 Meta 分析
引用本文:黄鹂,徐寅鹏,李方,郝红. 清开灵注射液辅助治疗小儿肺炎有效性和安全性的 Meta 分析[J]. 儿科药学杂志, 2018, 24(3): 6-9
作者姓名:黄鹂  徐寅鹏  李方  郝红
作者单位:(1. 郑州市妇幼保健院,河南郑州 450000; 2. 郑州市第九人民医院,河南郑州 450000)
摘    要:[摘要] 目的:系统评价清开灵注射液辅助治疗小儿肺炎的有效性和安全性。 方法:计算机检索Web of science、Embase、Cochrane Library、Pubmed、CNKI、万方数据库、VIP、中国生物医学数据库(CBM)电子数据库,纳入清开灵注射液辅助治疗小儿肺 炎的随机对照试验(RCT),由两名研究者独立选择试验和评价质量,提取有效数据,应用 RevMan 5.3.3 软件进行 Meta 分析。 结果:共纳入RCT 22 项,病例共计 2 400 例。 Meta 分析显示,在常规治疗基础上辅以清开灵注射液治疗小儿肺炎,在总有效率、 体温恢复正常时间、咳嗽消失时间、肺部啰音消失时间、呼吸频率改善时间、呕吐改善时间等方面均优于单纯常规治疗( P<0.05),但不会缩短住院时间(P>0.05)。 结论:现有文献支持清开灵注射液辅助治疗小儿肺炎,但由于现有支持文献质量不高, 仍有待更多高质量、大样本、多中心的RCT 加以验证。

关 键 词:清开灵注射液  小儿  肺炎  随机对照试验  Meta 分析

Meta-Analysis on Effectiveness and Safety of Qingkailing Injection in Treatment of Pediatric Pneumonia
Huang Li,Xu Yinpeng,Li Fang,Hao Hong. Meta-Analysis on Effectiveness and Safety of Qingkailing Injection in Treatment of Pediatric Pneumonia[J]. Journal of Pediatric Pharmacy, 2018, 24(3): 6-9
Authors:Huang Li  Xu Yinpeng  Li Fang  Hao Hong
Affiliation:1. Zhengzhou Maternal and Child Health Care Hospital, Henan Zhengzhou 450000, China; 2. The Ninth People''s Hospital of Zhengzhou, Henan Zhengzhou 450000, China
Abstract:[Abstract] Objective: To systemically review the effectiveness and safety of Qingkailing injection in the treatment of pediatricpneumonia. Methods: The databases of Web of science, Embase, Cochrane Libray, Pubmed, CNKI, Wan Fang, VIP and CBM wereretrieved for collecting the randomized controlled trials ( RCT) about the treatment of pediatric pneumonia with Qingkailing injection.The selection and data collection were conducted independently by two investigators, and the included studies were assessed. All the Meta-analyses were performed by Review Manager 5.3.3. Results: Twenty-two RCTs and 2,400 cases were included. From the resultsof Meta-analysis, the effectiveness of Qingkailing group was superior to the control group in the overall efficiency, defervescence time,cough disappeared time, rales disappeared time, breathing rate improvement time, vomiting improvement time ( P < 0.05), but thelength of hospital stay was not reduced by the addition of Qingkailing injection (P>0.05). Conclusion: The existing literature supportsthe treatment of pediatric pneumonia by Qingkailing injection. However, due to the low quality of supporting documents, more highquality, large samples and multi-center RCTs are still needed to be verified.
Keywords:
点击此处可从《儿科药学杂志》浏览原始摘要信息
点击此处可从《儿科药学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号